Scott Willoughby
General Counsel at SANGAMO THERAPEUTICS, INC.
Net worth: 402 095 $ as of 29/04/2024
Profile
Scott Willoughby is currently the Secretary, Senior VP & General Counsel at Sangamo Therapeutics, Inc. He previously worked as the Vice President-Deputy General Counsel & Head-Law at Achaogen, Inc. He received his undergraduate and graduate degrees from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/02/2024 | 799,393 ( 0.39% ) | 402 095 $ | 29/04/2024 |
Scott Willoughby active positions
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | General Counsel | - |
Former positions of Scott Willoughby
| Companies | Position | End |
|---|---|---|
| ACHAOGEN | General Counsel | - |
Training of Scott Willoughby
| University of California, Berkeley | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Scott Willoughby
